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modern medicine would be impossible. For this reason, 
GAs are widely considered to be one of the most important 
medical advances in the last 200 years. However, the mech-
anism of action of this diverse family of molecules remains 
poorly understood (1), as is the individual variation in pa-
tient response. This is an important problem, as a complete 
understanding of this mechanism will permit the design of 
molecules with improved safety and activity, and permit 
more accurate predictions of an individual’s response to 
GA. Such an advance would contribute to developing bet-
ter techniques to assess adequate levels of GA to administer 
and provide a personalized medicine approach to rapidly 
determine the best combination of GA agents for each pa-
tient. Furthermore, there is a risk of rare, but significant, 
complications presently associated with anesthetic admin-
istration, including malignant hyperthermia (2), succi-
nylcholine-related apnea (3), anaphylaxis (4), accidental 
awareness during general anesthesia (AAGA) (5), and 
GA-associated mortality (6, 7).
AAGA is defined as the recall of events or experiences 
that occurred during anesthesia and is a potentially devas-
tating complication affecting between 0.1% and 2% of all 
patients undergoing GA (8–10). Over three-quarters of 
the cases of AAGA are caused by a period of awareness 
under GA of less than 5 min duration. However, long-term 
adverse effects affect 41% of people with this condition 
(11). Patient recollection of AAGA range widely from 
nondistressing audiological recall to extremely distressing 
recollection of agony and paralysis, often associated with 
the development of posttraumatic stress disorder-like 
symptoms (10, 12). Multiple potential risk factors for 
AAGA have been identified by the recent NAP5 study, 
including the type of surgery (obstetric, cardiac, and pedi-
atric), higher patient American Society of Anesthesiologists 
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Anesthetic modulation of the membrane dipole potential 1963
score, and obesity (13). In addition, deficiencies in la-
beling and vigilance are also reported to contribute to 
AAGA (14) and an intrinsic (possibly genetic) resistance 
to GA has been suggested, with between 1.6% and 11% of 
patients reporting a previous history of AAGA (15, 16).
There is growing evidence to suggest that better monitor-
ing of the depth of anesthesia can reduce the risk of AAGA 
(17). Depth of anesthesia is routinely monitored using the 
isolated forearm technique to measure the responsiveness 
to command as a consciousness surrogate, and quantifying 
the end-tidal concentration of volatile anesthetics or plasma 
levels of intravenously administered agents to assess anes-
thetic delivery (9). Each of these techniques, however, is of 
limited clinical utility, as only 50% of patients who respond 
to command with an isolated forearm can later recall doing 
so (9) and monitoring the extent of anesthetic delivery is 
not the same as monitoring the actual effectiveness of the 
GA (8). Alternative methods of monitoring response to an-
esthesia and measuring the level of consciousness include 
recording the electrical activity of the brain with evoked po-
tentials and electroencephalograms. Despite the availability 
of these techniques for over 20 years (18), brain monitoring 
techniques are not routinely used in clinical practice. This 
is due to the difficulty in distinguishing brain activity from 
internal (muscular) and external (surgical device) interfer-
ence, and different excitatory and inhibitory effects of GAs 
on different ion channels giving rise to complex electroen-
cephalogram responses that can be further complicated by 
administration of non-GA drugs (8). As such, brain moni-
toring techniques are presently considered only qualitative 
indicators of GA depth (9, 19), meaning that there is a clear 
unmet need to develop techniques to accurately and quan-
titatively predict a patient’s response to anesthesia.
The membrane dipole potential describes an electrical 
potential that arises from the organization of dipoles 
within and on the membrane surface [for a comprehen-
sive review see (20)]. Ordinarily, the membrane dipole 
potential has a magnitude of between 200 and 400 mV, 
depending on membrane composition (21), and is inde-
pendent of membrane fluidity (22). The dipole potential 
is also sensitive to cholesterol content (23) and stereo-
specificity (24) and can be used to modulate the activity of 
the raft-associated (25) membrane protein, P-glycoprotein 
(26–28). The theory of GA-mediated modulation of 
membrane dipole potential was first proposed by Qin, 
Szabo, and Cafiso (29). The authors reported that addi-
tion of 1 minimum alveoli concentration (MAC) equiva-
lent concentrations of the GAs, enflurane, isoflurane, and 
halothane, to artificial membranes induced substantial 
reductions in the membrane dipole potential (10.5, 
10.5, and 6.7 mV, respectively). Other groups have 
also demonstrated that modulation of the membrane di-
pole potential can affect gramicidin A channel activity (30) 
[more recently with local anesthetics (31)] and sodium 
potassium pumps (32). Together, these data suggest that 
modulation of the membrane dipole potential could pro-
vide an attractive mechanism of indirect GA-induced mod-
ulation of membrane protein activity without requiring 
direct protein-ligand interactions.
The retina comprises the only portion of the CNS that 
can be readily visualized at the cellular level using nonin-
vasive imaging techniques, such as confocal scanning la-
ser ophthalmoscopy (33). Changes in retinal function 
have been reported using multifocal electroretinography, 
where isoflurane anesthesia induction in a porcine model 
resulted in a reduced RGC response (34). Building on 
this observation, we sought to determine the feasibility of 
monitoring retinal neuronal cell behavior in response to 
GA induction and whether this technique could ultimately 
be used to provide a screening tool to rapidly and quanti-
tatively assess a patient’s individual response to anesthe-
sia prior to undergoing surgery. In the present study, we 
sought to determine whether the small molecule ratiomet-
ric probe, di-8-ANEPPs, which becomes  strongly fluores-
cent only when incorporated into the cell membrane and 
has previously been used extensively to report on the 
membrane dipole potential (27, 28, 35), can be used to 
specifically report on anesthesia response using in vitro 
models. This was achieved by exposing di-8-ANEPPs- 
labeled artificial membrane (liposomes) and retinal 
neuronal cell lines to varying concentrations of either 
1-chloro-1,2,2-trifluorocyclobutane (F3) or 1,2-dichloro-
hexafluorocyclobutane (F6), an anesthetic/nonanesthetic 
pair with high structural similarity (Fig. 1) (36, 37). F3 has 
been previously reported to inhibit presynaptic voltage-gated 
sodium channels and potentiate GABAA chloride channels, 
while F6 has been found to have no effect on either channel 
(38, 39). The di-8-ANEPPs was chosen for this purpose, as 
methods to convert the fluorescence ratio measured to quan-
titative membrane dipole potential changes are established 
(23). The ratiometric nature of di-8-ANEPPs also ensures 
that this measurement is independent of changes in parti-
tioning of the probe between the membrane and aqueous 
milieu. The use of this probe with microscopic imaging tech-
niques has been reported (40) and it is increasingly being 
used for in vivo applications (41). A proposed schematic for 
such a screening device for use in preoperative conscious pa-
tients measuring their unique responses to subclinical doses 
of GA or GA combinations is discussed.
METHODS
Reagents
All materials and reagents were acquired at the highest purity 
from Sigma-Aldrich (Kent, UK) unless otherwise stated. All statis-
tical analyses were carried out using GraphPad Prism version 5.00 
for Windows (GraphPad Software, San Diego, CA).
Unilamellar liposome preparation
Egg phosphatidylcholine (PC) and cholesterol (ovine) were 
purchased from Avanti Polar Lipids (Alabaster, AL). Liposomes 
were prepared using a lipid film hydration technique (42). 
Briefly, 13 mM of PC100% or PC70%Cholesterol30% (molar ratios) 
were dissolved in a chloroform:methanol (5:1 ratio) solvent and 
dried under reduced pressure (50 mBar, 1 h at 45°C) to form a 
thin film. This film was rehydrated in sucrose-Tris buffer [280 mM 
sucrose, 10 mM Trizma-hydrochloride (pH 7.4), at 45°C for 1 h 
with agitation. The resulting liposome suspension was extruded 
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sequentially through polycarbonate filters with pores of 400, 
200, and 100 nm in diameter (Nucleopore Corp., Pleasanton, 
CA) using a handheld extruder (Mini-extruder; Avanti Polar Lipids) 
to produce a solution of unilamellar phospholipid vesicles of uni-
form size. Liposomes were labeled exclusively in the outer bilayer 
leaflet with di-8-ANEPPs, as described previously (27). Briefly,  
liposomes were incubated for 1.5 h at 37°C in the presence of 
di-8-ANEPPs (Thermo Fisher Scientific, Waltham, MA) dissolved 
in ethanol while protecting from light.
Liposome characterization by dynamic light scattering
Liposome size was determined using a Zetasizer Nano-ZS 
and Zetasizer 7.02 software (Malvern Instruments, Malvern, 
UK). Liposome suspensions were diluted to a concentration of 
400 M in sucrose-Tris buffer [280 mM sucrose, 10 mM Trizma-
hydrochloride (pH 7.4), and particle size recorded prior to and 
following 5 mM additions of F3 or F6 using dynamic light scatter-
ing. The particle diameter (Z-average) and polydispersity of the 
liposome population were recorded for three populations, 
from which the average particle diameter was calculated.
Immortalized retinal neuronal cell culture
An immortalized retinal neuronal cell line (a gift from Dr. 
Neeraj Agarwal, Department of Cell Biology and Genetics, Uni-
versity of North Texas Health Science Center, Fort Worth, TX) 
was used in this study as a model neuronal cell. These neurons 
express the typical retinal and neuronal markers, Thy-1, Brn-3a, 
and 3 tubulin (43–45), and are also reported to have similarities 
to the 661W photoreceptor cell line (46–48). Retinal neurons 
were cultured in DMEM (Invitrogen, Paisley, UK) supplemented 
with 10% heat-inactivated fetal bovine serum (Invitrogen). Peni-
cillin (100 U/ml) and streptomycin (100 mg/ml) were used to 
maintain the cells prior to experimentation.
The di-8-ANEPPs labeling of neuronal cell suspensions
Cell suspensions were counted using a trypan blue exclusion 
assay before harvesting by centrifugation (300 g, 5 min). Cells were 
labeled with di-8-ANEPPs according to the methods outlined by 
Asawakarn, Cladera, and O’Shea (28). Briefly, 10 M of di-8- 
ANEPPs were added to a suspension of cells (1 × 106 cells·ml1 su-
crose-Tris buffer) for 1.5 h at 37°C with mixing. Labeled cells were 
used for experiments within 2 h of labeling. When required, deple-
tion of cholesterol from cell membranes was achieved by treating 
di-8-ANEPPs cell suspensions for 1 min with 10 mM methyl--
cyclodextrin (MCD) before removal by centrifugation (300 g for 
5 min at 25°C) and resuspension in fresh sucrose buffer. Cells were 
used for experiments within 1 h of cholesterol depletion.
Spectral and ratiometric fluorescent recordings
Fluorescence measurements were taken during the addition of 
the desired amounts of F3, F6, or primary alcohols to suspensions of 
liposomes or cells (400 M lipid or 40,000 cells·ml1 sucrose-Tris 
buffer). Measurements  were  acquired  on  a  Cary  Eclipse  fluores-
cence spectrophotometer (Agilent Technologies) and during ac-
quisition samples were maintained at 37°C with magnetic stirring. 
Fluorescence difference spectra were obtained by subtracting the 
di-8-ANEPPs excitation spectra after the addition of agents of inter-
est from those obtained at baseline. Before subtraction, each spec-
trum was normalized to the integrated areas so that the difference 
spectra would reflect only the spectral shifts (28). Each difference 
spectrum was then normalized to an appropriate buffer control and 
a three-point moving average applied to reduce noise.
The di-8-ANEPPs ratiometric time series were obtained using 
excitation wavelengths of 420 and 520 nm and an emission wave-
length of 670 nm. Additions of 1, 2.5, or 5 mM of F3 or F6 were 
made after approximately 120 s of baseline recording and acqui-
sition was continued until no further change in di-8-ANEPPs flu-
orescence signal was observed (typically between 300 and 600 s). 
Data were fit using linear regression (indicative of no significant 
change in di-8-ANEPPs ratio on addition of ligands) or plateau 
followed one-phase exponential decay function equation 1:
 ( ) ( ){ } − − − 0 0 0 0Y = IF X < X , Y ,Plateau + Y Plateau × exp K × X X  
 (Eq. 1)
where X0 is the time at which the decay begins (fixed as the time 
of GA/non-GA addition), Y0 is the average Y value at time X0, 
plateau is the value of Y at infinite time, and K is the rate constant 
expressed as s1. The preferred model in each case was deter-
mined using an extra sum-of-squares F-test and the simpler model 
(linear regression) was selected, unless P < 0.05. The di-8-ANEPPs 
fluorescence ratios were converted into estimates of the membrane 
dipole potential using the calibration equation described by 
Starke-Peterkovic (23) (equation 2):
 
ψd
R + a
 =
b  
(Eq. 2)
where d is the membrane dipole potential, R is the ratiometric 
intensity of di-8-ANEPPs fluorescence ratio, a = 0.3 (±0.4), and 
Fig. 1. Properties of the volatile anesthetic (F3) and the nonimmobilizer (F6). F3 and F6 possess similar lipo-
philicity [calculated using ACD/LogP (octanol/water partition coefficient) 12.0], but distinct average molecu-
lar dipoles (36), as a result of the more unequal distribution of electronegative halogen atoms in F3 than in F6.
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b = 4.3 (±1.2) × 103 mV1. In agreement with previous studies, as 
the large errors associated with a and b are thought to arise from 
difficulties in determining the absolute value of d and we were 
principally concerned with relative changes in d, only the vari-
ance in R was considered in error calculations (40).
Membrane fluidity measurements
Liposomes were labeled with the fluorescent probe, 9-(dicya-
novinyl)julolidine (DCVJ), as described previously (49). Briefly, 
13 mM PC100% and PC70%Cholesterol30% liposomes were labeled 
with 45 M DCVJ for 1.5 h at 37°C. Liposomes were diluted 
to 400 M (1.5 M DCVJ) with HEPES saline buffer [10 mM 
HEPES, 140 mM sodium chloride (pH 7.4)]. Fluorescence emis-
sion (490 nm) was recorded at an excitation of 430 nm during 
the addition of DMSO, F3, and F6. Measurements were acquired 
using  a  Cary  Eclipse  fluorescence  spectrophotometer  (Agilent 
Technologies) and during acquisition, samples were maintained 
at 37°C with magnetic stirring. Under the assumption of con-
stant temperature and absorption, change in membrane fluidity 
(1/2) can be determined from DCVJ fluorescence emission on 
addition of DMSO, F3, or F6 using equation 3 (50);
 
η
η
 −     − 
1
x
1 1 o
2 2 o
I I
= 
I I  
(Eq. 3)
where I1 and I2 are the fluorescence emission from DCVJ before 
and after addition of an agent that modulates membrane fluidity, 
x is a constant equal to 0.6 for DCVJ, and Io is the signal due to 
nonfluorescent scattering, filter bleed-through, and ambient light 
effects (here Io = 110.23).
Cell viability
An AlamarBlue resazurin reduction assay (Invitrogen) was con-
ducted, as per the manufacturer’s instructions, to measure the po-
tential toxicity of all concentrations of anesthetic molecules used. 
Cells were incubated with the anesthetic compounds for 2 h at 
37°C with 5% CO2 and, following incubation, 10% AlamarBlue 
was added. A cell-free control containing 10% AlamarBlue only 
was included as a negative control. Fluorescence was measured on 
a Safire plate reader (Tecan, Zurich, Switzerland) with an excita-
tion wavelength of 570 nm and an emission wavelength of 585 nm. 
Percentage viability was determined by normalization to untreated 
(100% viable) and cell-free control (0% viable) groups.
RESULTS
Addition of F3, but not F6, to liposomes induced a dose-
dependent reduction in membrane dipole potential 
without membrane aggregation
Addition of 5 mM F3 or F6 to 400 M PC100% or 
PC70%Cholesterol30% liposomes did not induce signifi-
cant liposome aggregation, retaining comparable average 
population diameters and a polydispersity index of <0.2 in 
each case (Table 1 and Fig. 2). Titration of 1, 2.5, and 5 mM 
con centrations of F3 into di-8-ANEPPs-labeled PC100% and 
PC70%Cholesterol30% liposomes caused a concentration-de-
pendent red-shift in the excitation spectrum (Fig. 3A, B), 
indicative of a reduction in the membrane dipole po-
tential (27). The magnitude of the F3-induced red-shift 
in the di-8-ANEPPs excitation spectra was reduced in 
PC70%Cholesterol70% versus PC100% membranes, indicative 
of a smaller change in the membrane dipole potential in 
this membrane system. In contrast, no detectable spectral 
shift was recorded when liposomes were titrated with equiv-
alent concentrations of the nonimmobilizer, F6 (Fig. 3C, D).
Recording  changes  in di-8-ANEPPs 420/520 nm fluo-
rescence ratio over time confirmed that addition of F3 
to PC100% liposomes caused a concentration-dependent 
decrease in this parameter (Fig. 3D), while addition of 
equivalent concentrations of F6 did not cause any appar-
ent change (Fig. 3E). Titration of F3 fit best to a plateau 
followed by single exponential decay function equation 1, 
while those involving F6 typically best fit to a straight line 
function (indicative of no significant change in dipole po-
tential) or exponential decay function with nominal span. 
Figure 3F illustrates that the change in dipole potential 
on addition of F3 declined significantly and linearly with 
increasing concentration (F-test P < 0.0001 for PC100%- 
and PC70%Cholesterol30%-containing liposomes), while 
the addition of F6 had no such relationship (slope ± 95% 
CI; PC100% 0.39 ± 4.06 mV/mM F6 and PC70%Cholesterol30% 
0.15 ± 6.33 mV/mM F6, F-test, P = 0.82 and P = 0.95, re-
spectively). On comparing the gradient of each line, addi-
tion of F3 to cholesterol-containing liposomes was found 
to induce a smaller change in the membrane dipole po-
tential than addition to those comprised of PC alone 
(slope ± 95% CI; PC100% 19.45 ± 1.07 mV/mM F3 vs. 
PC70%Cholesterol30% 17.26 ± 0.65 mV/mM F3). Finally, 
the rate of dipole potential change on addition of F3 to 
PC100% liposomes was found to be almost twice that found 
on addition of this GA to PC70%Cholesterol30% membranes 
(Fig. 3G; 0.020 ± 0.003 s1 vs. 0.013 ± 0.002 s1, respec-
tively, two-tailed unpaired t-test, P = 0.0352).
Addition of primary alcohols (ethanol to dodecanol), 
but no tetradodecanol, to liposomes induced a dose-
dependent reduction in membrane dipole potential 
without membrane aggregation
The homologous series of primary alcohols between 
ethanol and dodecanol have long been established to pos-
sess increasing anesthetic potency with acyl chain length; 
however, between dodecanol and tetradodecanol, a cut-off 
point exists beyond which no anesthetic activity is ob-
served (51). To investigate this phenomenon, the ability of 
TABLE 1. Characteristics of liposomes in the presence or absence of F3 and F6
PC100% PC70%Cholesterol30%
Naïve Plus 5 mM F3 Plus 5 mM F6 Naïve Plus 5 mM F3 Plus 5 mM F6
Z-average diameter (nm ± SD) 142 (48) 144 (57) 141 (46) 163 (64) 164 (57) 163 (57)
Polydispersity index 0.099 0.110 0.060 0.105 0.088 0.084
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primary alcohols to modulate the membrane dipole po-
tential in PC100% artificial membranes was investigated 
(Fig. 4). Titration of primary alcohols with an acyl chain 
length between 2 and 12 carbons was found to induce a 
dose-dependent reduction in the membrane dipole po-
tential (Fig. 4C–I), with the concentration required to in-
duce a 5% reduction in dipole potential (18 mV) 
reducing with increasing acyl chain length (Fig. 4A). The 
concentration of primary alcohols required to induce a 
reduction in membrane dipole potential significantly cor-
related (Fig. 4B; slope = 0.9618 ± 0.09172, Spearman’s  
R  =  0.964, P = 0.0028) with  the EC50 of these molecules 
previously reported in tadpoles (51, 52). Titration of mem-
branes with tetradodecanol, however, did not induce a 
significant change in membrane dipole potential up to 
concentrations of 0.17 mM (Fig. 4J) with addition of greater 
concentrations of this alcohol, including visible precipita-
tion in the cuvette.
Addition of F3 and F6 to DCVJ-labeled artificial membrane 
systems induces a small, but physiologically irrelevant, 
increase in membrane fluidity
As the fluorescence emission of DCVJ is dependent on 
the dielectric constant of its environment (49), the effec-
tive labeling of membranes with DCVJ was first assessed by 
recording  the  fluorescence  emission  spectra  (Fig. 5A). 
Peak emission wavelength was observed at 487 nm for 
both membrane compositions, which is similar to that pre-
viously reported for PC-containing liposomes (49). A posi-
tive control to confirm the efficacy of this technique was 
the addition of DMSO (0.5% v/v to 2% v/v) to mem-
branes, as it is reported to increase membrane fluidity (53, 
54). A dose-dependent increase in membrane fluidity on 
addition of DMSO was observed (Fig. 5B, C). Addition of 
5 mM F3 or F6 to PC100% or PC70%Cholesterol30% liposomes 
induced a subtle increase in membrane fluidity (Fig. 5D); 
however, this increase was less than that expected for the 
change in membrane fluidity  that occurs as a result of a 
change temperature of 1°C (3.32 ± 1.05%, Table 2). This 
parameter was calculated using a previously published da-
taset  (49), where  a  change  in membrane fluidity  over  a 
known temperature range for PC-containing liposomes 
was used to estimate the percentage change in fluidity per 
1°C change in temperature from 35°C, not accounting for 
phase transitions.
Addition of F3, but not F6, to immortalized neuronal cells 
induced a dose-dependent reduction in membrane dipole 
potential without cell toxicity
Incubation of immortalized neuronal cell lines for 24 h 
with F3 and F6 up to concentrations of 10 mM was found to 
be well-tolerated and cause no significant decline in cell 
viability versus untreated controls using the AlamarBlue 
resazurin viability assay (Fig. 6C). The di-8-ANEPPs- 
labeled immortalized neuronal cells had an average basal 
membrane dipole potential of 367 ± 6 mV. Addition of F3 
was found to induce a dose-dependent decrease in di-
8-ANNEPs  fluorescence  ratio  at  420/520  nm  excitation, 
which fit best to a plateau followed by an exponential de-
cay (Fig. 6A). No detectable change in the di-8-ANEPPs 
fluorescent ratio was observed on addition of equivalent 
concentrations of F6 to cells (Fig. 6B). Plotting the change 
in terms of membrane dipole potential revealed that addi-
tion of F6 to cells up to concentrations of 5 mM induced 
no significant change in the membrane dipole potential. 
In contrast, the addition of F3 induced a dose-dependent 
and significant reduction in the dipole potential with a 
plateau 35 mV (Fig. 6D).
Fig. 2. Addition of 5 mM F3 or F6 did not induce liposome aggregation. Dynamic light scattering demonstrates that addition of 5 mM F3 
(A, C) or F6 (B, D) did not induce significant aggregation of PC100% (A, B) and PC70%Cholesterol30% (C, D) liposomes after incubation for 30 
min at 37°C (n = 3).
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Fig. 3. Comparing the interactions of F3 and F6 with artificial membrane systems and their effects on the membrane dipole potential. A–D: 
The fluorescence excitation spectra of di-8-ANEPPs-labeled liposomes shifts in response to F3, but not F6, indicative of a reduction in the 
membrane dipole potential. Fluorescence difference spectra obtained by subtracting excitation spectra (em = 670 nm) of di-8-ANEPPs- 
labeled PC100% [PC(100%)] (A, C) and PC70%Cholesterol30% [PC(70%)Chol(30%)] (B, D) liposomes (400 M) from those obtained on addi-
tion of the indicated concentrations of F3 (A, B) or F6 (C, D). Before subtraction, each spectrum was normalized to their integrated areas so 
that the difference spectra only reflected the spectral shift. In each experiment, temperature was maintained at 37°C. A dual wavelength 
ratiometric measurement of the membrane dipole potential was made on addition of F3 (E) or F6 (F) to di-8-ANEPPs-labeled PC100% lipo-
somes at the indicated time (arrows represent 5 mM additions). Samples were excited at 420 and 520 nm and emission recorded at 670 nm. 
The ratio R(420/520) was calculated (black dots) before each titration was fit (red line) to a plateau followed by one-phase decay (equation 1) 
or straight line (equation 2) using an extra sum-of-squares F-test to determine the best fitting model in each case. G: Addition of F3 (solid 
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Cholesterol depletion in neuronal cells permits greater 
anesthetic-mediated dipole potential changes
Depletion of membrane cholesterol content by pre-
treatment of immortalized neuronal cells with MCD 
significantly reduced their membrane dipole potential 
(295.6 ± 1 mV vs. 367 ± 6 mV, unpaired t-test, P < 0.0001) in 
agreement with previous studies (55). Subsequent applica-
tion of 5 mM of F3 to these cells induced a large reduction in 
the di-8-ANEPPs fluorescence ratio (Fig. 7A), which equated 
to a significantly greater (two-tailed unpaired t-test, P  = 
0.0061) change in the dipole potential compared with native 
cells subject to exposure to the same concentration of F3 
(Fig. 7B). The rate of F3-mediated dipole potential modula-
tion in native cells was significantly greater than that found in 
cholesterol-depleted cells (0.032 ± 0.01 s1 vs. 0.01 ± 0.002 s1, 
two-tailed unpaired t-test, P = 0.0122) (Fig. 7C).
DISCUSSION
This study sought to determine whether the difference 
in anesthetic activity of the well-described inducer/ 
noninducer pair, F3 and F6, could be explained by their 
ability to differentially modulate the membrane dipole po-
tential. Building on the work of Qin, Szabo, and Cafiso 
(29), who originally postulated that GA activity may be me-
diated by modulation of the membrane dipole potential, 
we sought to investigate this phenomenon using the ratio-
metric probe, di-8-ANEPPs, with artificial and cell mem-
brane systems. The first attempt to provide a theory to 
describe the mechanism of anesthetic action was proposed 
independently by Meyer and Overton in 1899, who de-
scribed a correlation between GA potency and oil solubility 
(56, 57). Since that time, several theories developed that 
lines), but not F6 (dashed lines), to PC100% (black) and PC70%Cholesterol30% (red) artificial membrane systems induced a dose-dependent 
reduction in the membrane dipole potential. All experiments n = 3; mean ± SEM. H: The rate of change in membrane dipole potential on 
addition of 5 mM F3 to PC100% liposomes was significantly greater (two tailed unpaired t-test, *P = 0.0352).
Fig. 4. Comparing the interactions of a series of primary alcohols with artificial membrane systems and 
their effects on the membrane dipole potential. A: The concentration of primary alcohol required to induce 
a 5% (18 mV) reduction in the membrane dipole potential versus acyl chain length indicates a significant 
negative correlation (slope = 0.48 ± 0.04, Spearman’s R = 0.964, P = 0.0028) between acyl chain length and 
dipole potential modulating effect until tetradodecanol (C14), where a clear cut-off point is observed. B: A 
significant positive correlation (slope = 0.9618 ± 0.09172, Spearman’s R = 0.964, P = 0.0028) between the effect 
of primary alcohols on dipole potential modulation and anesthetic potency previously reported in tadpoles 
(51, 52). C–J: The fluorescence excitation spectra of di-8-ANEPPs-labeled liposomes shifts in response to ad-
dition of primary alcohols [ethanol (C), propanol (D), butanol (E), hexanol (8.9 mM) (F), octanol (2.7 mM) 
(G), decanol (0.26 mM) (H), and dodecanol (0.15 mM) (I)] indicative of a reduction in the membrane di-
pole potential. Fluorescence difference spectra obtained by subtracting excitation spectra (em = 670 nm) of 
di-8-ANEPPs-labeled PC100% after addition of primary alcohols from baseline values, as previously described in 
the text. Interestingly, addition of 0.17 mM tetradodecanol to this artificial membrane system caused no such 
change in the membrane dipole potential (J).
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Anesthetic modulation of the membrane dipole potential 1969
postulated mechanisms as to how GAs may exert their ef-
fects through membrane interactions, including changes 
in membrane fluidity (58), volume expansion (59), or sur-
face pressure changes (60). Although these theories pro-
vide an attractive explanation as to how GAs with such a 
diverse family of molecular structures could induce similar 
effects in vivo, over the last three decades several important 
criticisms have been raised against membrane-mediated 
theories of GA action. These include: i) the observation 
that small, but physiologically normal, changes in body 
temperature can induce greater changes in membrane flu-
idity than those achieved by GA interactions (61, 62); ii) 
the existence of nonanesthetics/nonimmobilizers, a series 
of molecules whose structure and lipophilicity would sug-
gest GA activity, but do not induce anesthesia (63, 64); iii) 
an unexpected cut-off point in the positive correlation be-
tween n-alkane molecular weight and potency despite the 
oil partition coefficient continuing to increase (1); and iv) 
enantiomers of anesthetic molecules have varying degrees 
of anesthetic actions, an unexpected result given the achi-
rality of the proposed membrane-based mechanisms of 
action (1).
These criticisms, combined with a seminal study by 
Franks and Lieb (65) that reported the affinity of GAs for 
the hydrophobic binding cavity in luciferase also obey the 
Meyer-Overton relationship, led to a shift in interest more 
toward protein-based theories of GA action. Since that 
time, a large number of predominantly protein targets for 
anesthetics have been identified, including activation of in-
hibitory ion channels, such as GABAA, and suppression of 
excitatory glutamatergic ion channels, such as NMDA re-
ceptors (66). Although a wealth of evidence now shows that 
GAs can modulate ion channel activity and single residue 
genetic modification of such channels reduces GA potency 
in vitro and in vivo (62, 67–69), there are few examples of 
a clear structure-function relationship between GAs and 
their ion channel targets (1). Furthermore, given the wide 
range of potential GA targets, a distinct lack of chemical 
antagonists, acquired tolerance, and high conservation of 
potency across the entire animal kingdom suggests that there 
are likely to be multiple contributing systems to GA activity, 
rather than a single unitary site of action (70–72). A possi-
ble solution to this problem can be found when consider-
ing that, in addition to direct ligand-protein interactions, 
Fig. 5.  The influence of F3 and F6 on membrane fluidity. A: Normalized emission spectra of DCVJ-labeled 
PC100% liposomes (400 M liposomes with 1.5 M dye) in HEPES buffered saline (pH 7.4) at 37°C exhibits 
peak fluorescence emission of 487 nm, similar to that previously reported for PC liposomes (49). B: Addition 
of 2% DMSO to DCVJ-labeled PC100% liposomes at 37°C induced a reduction in DCVJ fluorescence indicative 
of an increase in membrane fluidity in agreement with the reported behavior of this molecule in PC- and 
cholesterol-containing membranes  (53,  54). C: A  concentration-dependent  change  in membrane fluidity 
(DCVJ fluorescence intensity ratio) was observed on addition of DMSO to PC100% and PC70%Cholesterol30% 
[PC70%Chol30%] liposomes at 37°C. On fitting this data to a linear regression model, DMSO was found to in-
duce a significantly greater change in membrane fluidity in PC70%Chol30% membranes, perhaps indicative of 
disassembly of cholesterol-containing domains (extra sum-of-squares F-test, P = 0.0246). D: Addition of F3 and 
F6 to liposomes was observed to induce an increase in membrane fluidity with F3 modulating the membrane 
fluidity to a greater extent than F6. The extent of membrane fluidity modulation was, however, slight and less 
than that typically attributed to a change in temperature of 1°C (Table 2). As mammalian brain temperatures 
are reported to fluctuate under physiological conditions by up to 3°C (93), this strongly suggests that modula-
tion of membrane fluidity is not responsible for GA action.
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modulation of membrane protein function can also be 
achieved indirectly by modulating lipid-protein interac-
tions, particularly at the site of membrane rafts (73). For 
example, both GABAA and NMDA receptor activity are rec-
ognized to be raft associated (74, 75) and their raft distri-
bution is reported to change in response to activation and 
psychopharmacological challenge (76).
The existence of anesthetic/nonimmobilizer pairs, such 
as F3 and F6, with similar structures and oil partition coef-
ficients, but very different anesthetic activity, has provided 
both a challenge to determining the processes underlying 
GA induction and an opportunity to better elucidate their 
mechanism of action by identifying subtle differences in 
behavior. The present study provides evidence to support 
the theory that modulation of the membrane dipole poten-
tial may contribute to the difference in anesthetic activity 
between the anesthetic/nonanesthetic pair, F3 and F6. This 
study also provides the first evidence to demonstrate GA-
mediated modulation of the membrane dipole potential in 
a living neuronal cell.
Despite their structural similarities and lipophilic na-
ture, F3 and F6 possess distinct average dipole moments 
[3.17 and 0.78 D, respectively (36)] (Fig. 1). As larger dipole 
moments are reported to impede the penetration of small 
molecules into biological membranes (77), F3 would be ex-
pected to localize more toward the membrane interface 
TABLE  2.  The influence of temperature changes on membrane fluidity
Membrane  
Compositiona Technique (Probe)a Temperature (°C)a  (cP)a  (cP)  (%/°C)b
DPPC Quantum yield (DCVJ) 10–60 120–70 50 1.05
DPPC Quantum yield (DCQEB) 10–60 30–3 27 3.27
DPPC fluorescence depolarization (perylene) 25–45 940–94 846 8.18
DPPC fluorescence depolarization  
(diphenylhexatriene)
10–60 1,000–50 950 3.62
DPPC intramolecular excimer formation  
(dipyrenylpropane)
20–50 30–18 12 1.67
DMPC Intramolecular excimer formation  
(dipyrenylpropane)
10–60 125–38 87 2.13
Mean (SE) 3.32 (1.05)
a Derived from reference (49).
b Not accounting for phase transitions.
Fig. 6. The interaction of F3 and F6 with neuronal cells. Addition (black arrows) of 5 mM F3 (A), but not 5 mM F6 (B), induced a reduction 
in the di-8-ANEPPs fluorescence ratio indicative of a reduction in the membrane dipole potential. C: Immortalized neuronal cell cultures 
were incubated in the presence of varying concentration of F3 or F6 for 24 h before cell viability was assessed using an AlamarBlue assay. No 
significant change in cell viability was observed on addition of up to 10 mM concentrations of either agent. D: The change in membrane 
dipole potential induced on addition of F3 or F6 to immortalized neuronal cells labeled with di-8-ANEPPs. Profiles were fit to a simple hyper-
bolic equation or straight line and the best fitting model determined by F-test, n > 3, mean ± SEM.
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Anesthetic modulation of the membrane dipole potential 1971
compared with F6, which would instead be found more to-
ward the hydrophobic membrane interior. The membrane 
dipole potential is, itself, comprised of the electrical di-
poles associated with the carbonyl group and oxygen-
bonded phosphate components of the membrane surface 
in conjunction with the permanent molecular dipoles of 
water molecules occupying a restricted conformation in 
the membrane solvation shell at this site (78–81). The lo-
calization of F3 at the membrane interface would, there-
fore, be expected to more strongly influence the membrane 
dipole potential than its nonimmobilizer counterpart, F6.
Experimental evidence to support the difference in 
membrane distribution of F3 and F6 was presented in two 
studies by North and Cafiso (82) and Tang, Yan, and Xu 
(83), who used 2H and 19F NMR to report that, while F3 
preferentially localizes to the membrane interface, F6 local-
izes to the hydrophobic core of the membrane. Interest-
ingly, the authors also reported that halothane, isoflurane, 
and  enflurane  also  localized  at  the membrane  interface, 
perhaps suggesting a shared mechanism of action between 
these molecules. These observations were supported by 
subsequent studies by Tang et al. (84) and Tang, Sim-
placeanu, and Xu (85), who used NMR to confirm the 
site of the water-lipid-protein interface as the site of F3 
interaction with gramicidin A channels. More recently, 
Bondarenko et al. (86) reported that using 1H and 15N 
solution-state NMR to show that addition of millimolar 
concentrations of F3 and isoflurane to nAChR-2 subunit-
loaded dodecyl phosphocholine micelles resulted in a 
change in -helix conformation through shortening and 
lengthening of helix hydrogen bonds. Furthermore, the 
“unsaturatable” nature of some of these chemical shifts at 
high GA concentrations suggests a nonspecific mechanism 
of action. This work is in agreement with recent observa-
tions suggesting that micelles also possess a dipole poten-
tial (87) and previous work demonstrating that modulation 
of membrane dipole potential can induce changes in 
membrane peptide conformation (80). Based on this data, 
the difference in average dipole moment leading to the 
distinct membrane localization of F3 and F6 could offer an 
attractive mechanism to explain the difference in the abil-
ity of these molecules to modulate the membrane dipole 
potential.
To further test the hypothesis that modulation of mem-
brane dipole potential may provide a potential mechanism 
of anesthetic action, a series of primary alcohols, which 
were previously reported to have anesthetic effects (51), 
were titrated into artificial membranes and the change in 
dipole potential recorded. A significant negative correla-
tion between acyl chain length and ability to modulate the 
membrane dipole potential was observed. The concentra-
tion of primary alcohol required to induce a 5% change in 
the membrane dipole potential of PC100% liposomes (18 
mV) was found to strongly correlate with the reported EC50 
of each molecule, including a cut-off in dipole potential 
modulation at C14 (tetradodecanol) (51), despite reports 
that primary alcohols continue to partition into lipid bilay-
ers with increasing chain length up to 15 carbons in length 
(88) and no qualitative difference in the ability of the anes-
thetic alcohol, dodecanol, and nonanesthetic alcohol, tet-
radodecanol, to achieve effective levels in tadpoles, 
suggesting that this cut-off is not due to the reducing solu-
bility of longer chain alcohols (89). This observation is in 
agreement with previous work by Ingolfsson and Anderson 
(90), who reported that the presence of such alcohol cut-
offs can exist in the absence of a specific alcohol binding 
site within the system (i.e., an alcohol binding protein), 
supportive of indirect modulation of membrane properties 
as a mechanism of anesthesia induction.
Previous membrane-based explanations for the cut-off 
point between dodecanol and tetradodecanol include the 
observation by Chiou et al. (91), who, using FTIR, found 
that hydrogen bond breaking activity of the primary alcohol 
series at the membrane-water interface correlates with anes-
thetic potency and includes a marked cut-off point between 
10 and 14 carbons. A similar hydrogen-bond breaking 
propensity  for  fluorocarbon  anesthetics  had  previously 
been reported by Di Paolo and Sandorfy (92); although 
in both cases, the process linking interfacial hydrogen-
bond breaking and anesthesia induction remained elusive. 
Fig. 7. Depletion of cholesterol using MCD in neuronal cells leads to larger changes in the dipole potential. Example experiment of ratio-
metric imaging (simultaneous 420/520 nm scans) of MCD-treated cells treated with 5 mM F3 (A) (arrow represents the addition of F3). 
Depletion of cholesterol caused a significantly greater change in the span (B) and rate (C) of the decrease in dipole potential following 
5 mM F3 in ratiometric titration experiments (**P = 0.0028 and *P = 0.0122, respectively).
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As previously described, the membrane dipole potential is 
comprised of the electrical dipoles associated with the car-
bonyl group and oxygen-bonded phosphate components of 
the membrane surface in conjunction with the permanent 
molecular dipoles of water molecules occupying a restricted 
conformation in the membrane solvation shell at this site 
(78–81). Together, these observations suggest that anes-
thetic-induced disruption of lipid-water hydrogen bonds at 
the membrane-water interface could explain the changes in 
the membrane dipole potential induced by F3 and primary 
alcohols up to dodecanol, but not tetradodecanol.
Although independent of the membrane dipole poten-
tial  (22),  modulation  of  membrane  fluidity  has  been  
postulated as an alternative mechanism of anesthetic action 
(58). Using DCVJ,  a  small  increase  in membrane fluidity 
was observed on addition of F3 and F6 to PC100% and 
PC70%Cholesterol30%  liposomes and  the change  in fluidity 
induced by F3 was found to be greater than F6 (although 
this difference was not significant). The change in fluidity 
was, however, found to be less than that induced by a 1°C 
temperature change (Table 2), in agreement with previous 
observations for other GA/membrane interactions (61, 
62). This result strongly suggests that changes in membrane 
fluidity are, therefore, not responsible for GA activity, as the 
temperature of the mammalian brain is reported to fluctu-
ate by up to 3°C under physiological conditions (93).
The addition of DMSO to DCVJ-labeled PC100% and 
PC70%Cholesterol30% liposomes (Fig. 5B, C) was found to 
induce a relatively large dose-dependent increase in mem-
brane fluidity, despite DMSO possessing no anesthetic activ-
ity (94). A significantly greater change in membrane fluidity 
was observed on addition of DMSO to PC70%Cholesterol30% 
membranes  (slope:  23.0  ±  1.1%  vs.  26.1  ±  0.7% /1% 
(v/v) DMSO, extra sum-of-squares F-test, P = 0.0246). The 
marked change in membrane fluidity in response to these 
relatively low concentrations of DMSO may offer a novel 
mechanism for the recently reported toxicity of <2% con-
centrations of DMSO in vitro and in vivo (95), recognizing 
a potential link between membrane fluidity and apoptosis 
induction (96).
This study provides the first evidence to suggest that ad-
dition of F3 (but not F6) to immortalized neuronal cells can 
induce a dose-dependent reduction in membrane dipole 
potential equivalent to 19.1 ± 4.5 mV at 1 MAC equivalent 
without negatively impacting cell viability. Immortalized 
cell lines provide an attractive model for this work, owing 
to the clonal nature of the cells and the large number re-
quired for these experiments, which precluded isolation 
from primary tissues. A limitation of working with immor-
talized cells, however, is that they serve only as a model of 
retinal neuron cell behavior, which may not reflect the be-
havior of cells in vivo.
While it is extremely difficult to extrapolate clinically rel-
evant anesthetic concentration for in vitro studies from pa-
rameters such as MAC (71), several studies have assessed 
the concentrations of F3 required to modulate the func-
tion of proteins linked to GA activity in vitro. The major-
ity of these studies were conducted by examining the effect 
of GAs using two-electrode voltage clamp recording in 
Xenopus oocytes expressing membrane proteins with sus-
pected GA activity. Low millimolar concentrations of F3 
(typically 0.2–5 mM), but not F6, were reported to strongly 
potentiate the action of glycine on homomeric -glycine re-
ceptor subunits in a concentration-dependent manner 
(97); inhibit muscarinic m1 receptor-induced Ca2q-depen-
dent chloride currents (98); inhibit a number of potassium 
channels, including ERG-1, KCNQ2/3, and GIRK (99); 
and inhibit synaptosomal sodium channels (38, 100) and 
NMDA receptors (68). Beyond this model, Liachenko et al.
(101) investigated the effects of clinically relevant concen-
trations (2 MAC) of F3 and F6 on K
+-evoked glutamate and 
GABA release from isolated and super-fused cerebrocorti-
cal slices from mice. F3  (1.6 ± 0.11 mM), but not F6, was 
reported to suppress evoked glutamate release by 70%, but 
had no significant effects on evoked GABA release, without 
causing any nonspecific or irreversible changes in the brain 
slices. In summary, the concentrations of F3 reported mod-
ulating the membrane dipole potential in both artificial 
and neuronal membrane systems closely match those re-
ported to modulate a range of membrane protein func-
tions in other models.
The incorporation of 30% molar cholesterol into PC li-
posomes was found to reduce both the magnitude and rate 
of change in dipole potential on addition of F3. In agree-
ment with this observation, depletion of cholesterol from 
neuronal cell membranes with MCD was found to in-
crease the change in membrane dipole potential on addi-
tion of F3 by almost 50%. Surprisingly, the rate of dipole 
potential change on depletion of membrane cholesterol 
was found to decrease. This may be indicative of the influ-
ence of other membrane components (i.e., charged lipids 
or sphingomyelin) on the interactions of F3 with the mem-
brane or be a result of the recognized limitations of MCD-
mediated cholesterol depletion (102). These observations 
are in agreement with previous work that reported that 
cholesterol can inhibit the pentobarbital-mediated sup-
pression of human brain sodium channels in planar lipid 
bilayers in a concentration-dependent manner (103). A 
possible mechanism for this process is the exclusion of 
F3 from cholesterol-containing membrane microdomains 
(rafts) (104), dynamic structures that may offer an addi-
tional level of control over membrane protein function. Fu-
ture work will seek to isolate raft and nonraft domains from 
immortalized retinal neuronal cells in order to quantitatively 
determine the distribution of F3 and F6 between these dis-
tinct membrane domains.
A membrane dipole potential-mediated mechanism of 
anesthesia action can also offer an explanation why enan-
tiomers of anesthetic molecules can possess different ac-
tivities. An often overlooked, but important, property of 
biological membranes is that they also possess chirality. For 
example, PC possesses a chiral center at the position of the 
C2 carbon of the glycerol backbone and the plasma mem-
brane comprises L-optical isomers of PC (105). With the 
growing recognition that enantioselective interactions be-
tween membrane constituents can determine the physical 
properties of membranes (106), including the formation 
and organization of membrane rafts (107), it is an intriguing 
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Anesthetic modulation of the membrane dipole potential 1973
hypothesis that enantiomeric anesthetics, interacting at 
the membrane interface at the site of the membrane di-
pole potential, may elicit varying degrees of activity with-
out requiring direct protein interactions. Support for this 
view can be found in recent work by Bandari et al. (24), 
who present intriguing evidence to suggest that the mem-
brane dipole potential is sensitive to the stereospecificity 
of cholesterol, which can significantly alter the dipolar 
field at the membrane interface that can, in turn, modu-
late membrane protein activity.
Confocal scanning laser ophthalmoscopy is an estab-
lished technique for noninvasive retinal visualization that 
is increasingly being combined with fluorescent contrast 
agents to increase the amount of information that can 
be extracted for retinal imaging purposes. For example, 
fluorescein and indocyanine green angiography permits 
diagnosis of retinal disorders via visualization of retinal 
and choroidal vasculature abnormalities (108) and, more 
recently, our group has developed the DARC (detection 
of  apoptotic  retinal  cell)  technology  that  uses  fluores-
cently labeled annexin A5 to provide a snapshot of the 
number of dying cells in the retina at a specific time 
point (109, 110). Assuming modulation of membrane di-
pole potential is a common feature among other GA mol-
ecules, the ratiometric probe, di-8-ANEPPs, could provide 
a useful tool to monitor changes in the membrane dipole 
potential in response to GA induction using retinal im-
aging approaches. Future work will seek to establish 
whether modulation of membrane dipole potential can 
be used to predict anesthetic sensitivity for a broad range 
of anesthetic species and develop both a noninvasive ad-
ministration technique of the di-8-ANEPPs contrast agent 
in  rodent models  and  a  ratiometric  fluorescence-based 
imaging device for the real-time screening of patients’ 
responses to anesthesia in a preoperative environment. 
We anticipate that patients susceptible to AAGA will ex-
hibit a reduced modulation in the membrane dipole po-
tential in response to administration of subclinical doses 
of GAs, which could be easily monitored by noninvasive 
ophthalmic examination using ratiometric confocal scan-
ning laser ophthalmoscopy, such as the device outlined 
in Fig. 8.
As AAGA may be the result of a number of factors, in-
cluding failure to deliver or maintain sufficient GA in the 
CNS [perhaps due to differences in the activity of protein 
transporters or drug metabolism (111)], the authors postu-
late that AAGA-associated changes in GA sensitivity could 
manifest as: i) a difference in the onset of CNS dipole po-
tential modulation after GA administration; ii) the magni-
tude of the resulting dipole potential change; or iii) a 
reduction in the duration of the changed dipole potential 
state after administration of a fixed subclinical dose of GA. 
This hypothesis assumes that there exists a strong associa-
tion between the changes in membrane dipole in the CNS 
and GA activity in anesthetics in addition to F3, enflurane, 
isoflurane, and halothane, described previously (29), and 
that retinal response to GA induction mirrors changes in 
the rest of the CNS.
Fig. 8. A proposed schematic of a confocal scanning laser ophthalmoscopy-based technique for monitoring GA susceptibility using di-
8-ANEPPs-mediated ratiometric real-time monitoring of the membrane dipole potential. A: The di-8-ANEPPs contrast agent will be admin-
istered locally (topically) prior to surgery to permit retinal membrane dipole potential values to be recorded before administration of 
subclinical doses of GA. B: After GA administration, real-time depth of GA monitoring could be achieved by recording the di-8-ANEPPs fluo-
rescent ratio; as the retina is part of the CNS, we anticipate that changes in the retinal membrane dipole potential recorded in this tissue will 
mirror changes reported in the brain in response to GA. These changes could present as differences in the onset of CNS dipole potential 
modulation after GA administration (a), the magnitude of the resulting dipole potential change (b), or a reduction in the duration of the 
changed dipole potential state after administration of a fixed subclinical dose of GA (c). Changes could manifest as a result of systemic dif-
ferences in GA delivery to the CNS (i.e., changes in multidrug efflux pump activity or GA metabolism) and not necessarily simply changes 
in CNS membrane composition in individuals susceptible to AAGA.
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In summary, this work supports previous observations 
that suggest that modulation of the membrane dipole po-
tential could provide a mechanism to explain the differ-
ence in anesthetic action of the inducer/noninducer pair, 
F3 and F6, and the existence of a cut-off in anesthetic activ-
ity in the primary alcohol series. An advantage of this mem-
brane-mediated mechanism of GA action is that it may 
address some of the limitations of existing membrane-me-
diated hypotheses, including the existence of nonimmobi-
lizers and perhaps even stereospecificity (24). Assuming 
that other GAs behave in a similar manner to those out-
lined here and in previous work (29), we anticipate that the 
process of dipole potential-mediated GA action will mani-
fest via indirect modulation of membrane protein func-
tion, such as the type II interactions recently described by 
Richens et al. (73). We propose the use of di-8-ANEPPs-
mediated reporting of the membrane dipole potential as a 
technique to preoperatively screen patients for anesthetic 
susceptibility and risk of AAGA by combining this probe 
with confocal scanning laser ophthalmoscopy.
The authors are grateful to Professor Paul O’Shea (University of 
Nottingham) for useful discussion.
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